Document Detail


Ventricular arrhythmia following short-acting nifedipine administration.
MedLine Citation:
PMID:  15880273     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Short-acting nifedipine is still advocated for use in children with severe hypertension, but is no longer recommended for use in adults because of adverse effects from rapid blood pressure reduction. A 19 year-old adolescent with symptomatic, severe hypertension (blood pressure 180/120) received 10 mg of short-acting nifedipine sublingually for blood pressure reduction. Within minutes after the dose, the patient complained of palpitations. Tachycardia (heart rate 100 beats per minute) and bigeminy were noted on the cardiac monitor. The bigeminy resolved but premature ventricular contractions were noted for the duration of her hospital stay. We hypothesize that reflex sympathetic activation following an abrupt drop in blood pressure may cause arrhythmias because of elevated catecholamine levels. Given this, it may be more appropriate to treat severe hypertension in children with intravenous antihypertensive agents that can be titrated to produce controlled reductions in blood pressure.
Authors:
M Patricia Castaneda; Christine A Walsh; Robert P Woroniecki; Marcela Del Rio; Joseph T Flynn
Related Documents :
2495813 - Effect of the combination of alinidine and other anti-anginal drugs on heart rate and b...
2856703 - Comparison of the haemodynamic profiles of the hypotensive action of verapamil and carv...
20597833 - Mobile telemonitoring for achieving tighter targets of blood pressure control in patien...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2005-05-07
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  20     ISSN:  0931-041X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-06-16     Completed Date:  2005-10-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1000-2     Citation Subset:  IM    
Affiliation:
Division of Pediatric Nephrology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Sublingual
Adult
Female
Humans
Hypertension / drug therapy*
Nifedipine / administration & dosage,  adverse effects*,  therapeutic use
Tachycardia, Ventricular / chemically induced*
Vasodilator Agents / administration & dosage,  adverse effects*,  therapeutic use
Ventricular Premature Complexes / chemically induced*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neonatal transient renal failure with renal medullary hyperechogenicity: clinical and laboratory fea...
Next Document:  The effects of cetrimide-chlorhexidine combination on the hepato-pancreatico-biliary system.